Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Renal Failure Chronic Requiring Hemodialysis: early-phase trial registry
A small indexed set (4 trials) with no open enrollment listed right now.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · none currently recruiting · #4,115 of 28,707 conditions by registered trial count
Renal Failure Chronic Requiring Hemodialysis: 4 US clinical trials tracked, none currently recruiting.
Renal Failure Chronic Requiring Hemodialysis is the subject of 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), running 1 of these trials.
Enrollment posture brief
Registry condition renal-failure-chronic-requiring-hemodialysis
OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Renal Failure Chronic Requiring Hemodialysis has no open enrollment in this registry pull (4 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Renal Failure Chronic Requiring Hemodialysis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Renal Failure Chronic Requiring Hemodialysis is recruiting below its size-band peers.
0 of 4 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
4 total, page 1 of 1
VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC
University of Pennsylvania
NCT02685995
Mechanisms of Intradialytic Hypertension
Emory University
NCT01947673
Study to Evaluate Daptomycin Given During Dialysis and After Dialysis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
NCT00882557
A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis
Vantive Health
NCT01181544
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Renal Failure Chronic Requiring Hemodialysis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Renal Failure Chronic Requiring Hemodialysis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Renal Failure Chronic Requiring Hemodialysis page
4 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Renal Failure Chronic Requiring Hemodialysis trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) sponsors the most Renal Failure Chronic Requiring Hemodialysis trials on record, review their full trial history before evaluating a specific study. See Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Renal Failure Chronic Requiring Hemodialysis condition card totals 4 registered trials; most-linked intervention Palindrome TDC; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.